In an associated Commentary titled Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward, Juan Brito, MD , from the Mayo Clinic, and coauthors, stated the following: this study stands out for its large scale and robust methodology
Treatment requires specialist prescribing, regular monitoring for adverse effects including pancreatitis, and integration with lifestyle modifications
Factors that accelerate weight loss include: High baseline insulin levels Significant visceral fat Pre-diabetes or metabolic syndrome Strong response to appetite suppression Factors that slow progress include: Perimenopause or menopause Low testosterone in men Thyroid dysfunction Chronic stress and poor sleep This is why medical monitoring and lab work matter
While this Guidance suggested that such activities would to be considered prohibited wholesaling or redistribution by 503B facilities, this Guidance did not indicate what role 503B facilities would be occupying when they compounded the products